Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Single Head, Dual-Head, Syringeless Injectors), Product (Injector Systems, Consumables), Application (Radiology, Interventional Cardiology, Interventional Radiology), End-User (Hospitals, Ambulatory Surgical Centres, Diagnostics Centres) – Industry Trends and Forecast to 2031.
.
The Global Contrast Media Injectors Market size was valued at USD 1.63 USD Billion in 2023.
The Global Contrast Media Injectors Market is projected to grow at a CAGR of 7.75% during the forecast period of 2024 to 2031.
The major players operating in the market include Boehringer Ingelheim International GmbH, Sanofi, Novartis AG, Merck Sharp & Dohme Corp., Bracco Imaging S.p.A., Guerbet, Medtron AG, Bayer AG, ulrich medical, GENERAL ELECTRIC COMPANY, VIVID IMAGING, Sino Medical Sciences Technology , AngioDynamics, APOLLO RT Co. Ltd, Nemoto, Messe Düsseldorf GmbH, Hilin Life Products, Jodas Expoim, Lantheus Medical Imaging, Magnus Health, TAEJOON PHARM, Spago Nanomedical AB.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
